by In2Pharma | Jun 7, 2023 | News
Belgium/Luxembourg On Thursday 1st of June, the Luxembourg authority DPM published the “Guideline on BE/LU packages”. This guideline assists applicants/MAH in creating or updating a common BE/LU pack and Product information (PI) for medicinal products for...
by In2Pharma | May 17, 2023 | News
Belgium Due to the publication of the Royal decree about fees for raw materials and products (RD of 13 novembre 2011), the amount of the fees for notifications of food supplements has been modified. From May 21st 2023, the fee for a food supplement notification will...
by In2Pharma | May 10, 2023 | News
Belgium The Mixed Committee of the FAMHP (which examines the ‘grey zone’ products) has issued a new guideline regarding the use of D-mannose in food supplements. Products with an amount of D-mannose higher than 750 mg/day can have a significant...
by In2Pharma | Mar 28, 2023 | News
Belgium As from the start of 2023, a new system for funding market surveillance of medical devices by FAMHP applies. Unlike before, this will no longer be limited to the sale of medical devices to retailers and end users. All actors that carry out an activity...
by In2Pharma | Mar 22, 2023 | News
Belgium The Royal Decree of April 7, 1995 on information and publicity of medicinal products for human use, describing which diplomas are eligible for recognition as RIP is being amended. The adaptation is made to follow the evolution in terminology of the relevant...
